Getting annual flu shot won't weaken your immune system

November 21, 2017

(HealthDay)—There's no evidence to support the notion that people who get the flu vaccine every year somehow "weaken" their immune system over time, researchers say.

In fact, annual vaccination seemed tied to stronger immune cell activity, according to the Norwegian research team.

That's even true for years where the is a poor match for actually circulating, as happened in the 2016-2017 season, the findings suggest.

The study was led by Rebecca Cox of the University of Bergen's department of clinical science. Her group tracked the immune system health of 250 . Some of the participants got the flu shot beginning in 2009 and then every year thereafter, while others only got the shot in 2009, but then no shot between 2010 and 2013.

Immune system antibodies that showed activity against the flu "persisted above the protective levels in [the] repeatedly vaccinated adults," the team reported.

Specifically, immune system CD4 and CD8 T-cells—which target viruses—had more disease-fighting capability "after multiple annual vaccinations" than those in people who didn't get the yearly flu shot, the investigators found.

The research team noted that even though the flu shot has been in use for more than half a century, there have been very few studies that have tracked the immune system health of recipients in such a rigorous way.

Dr. Len Horovitz is an expert on influenza and a pulmonary specialist at Lenox Hill Hospital in New York City. He reviewed the findings and said the study "shows that those that are annually vaccinated do not lose their second line of defense [against viruses]. This makes the case for annual vaccinations even stronger."

Infection expert Dr. Debra Spicehandler agreed.

"Influenza yearly protection is important for preventing the flu," said Spicehandler, who is co-chief of infectious diseases at Northern Westchester Hospital in Mount Kisco, N.Y. "Each year the vaccine is made up of different strains to protect against what viruses are prevalent."

Spicehandler believes the Norwegian trial "shows that annual vaccination does not decrease natural immunity or increase susceptibility, [even] when not all the prevalent strains are covered by the vaccine."

The U.S. Centers for Disease Control and Prevention is recommending that everyone 6 months of age and older receive this season's flu shot, with only rare exceptions.

The report by Cox's team was published in the Journal of Infectious Diseases.

Explore further: Annual influenza vaccination does not prevent natural immunity

More information: Len Horovitz, M.D., pulmonary specialist, Lenox Hill Hospital, New York City; Debra Spicehandler, M.D., co-chief of infectious diseases, Northern Westchester Hospital, Mount Kisco, N.Y.; University of Bergen, news release, Nov. 13, 2017

Find more details on flu shot recommendations at the U.S. Centers for Disease Control and Prevention.

Related Stories

Annual influenza vaccination does not prevent natural immunity

November 14, 2017
Earlier studies have suggested that having repeated annual influenza vaccination can prevent natural immunity to the virus, and potentially increase the susceptibility to influenza illness in the event of a pandemic, or when ...

Experts say flu season could be severe this year

September 22, 2017
If last year's active flu season and this year's severe season in the Southern Hemisphere is any indication of what flu season will look like across the country beginning this fall, then it's important to get vaccinated soon ...

Team develops new broadly protective vaccines for H3N2 influenza

November 2, 2017
A collaborative research and development partnership between researchers at the University of Georgia and Sanofi Pasteur, the largest influenza vaccine manufacturer in the world, has resulted in the identification of a vaccine ...

H3N2 mutation in last year's flu vaccine responsible for lowered efficacy

November 6, 2017
The low efficacy of last year's influenza vaccine can be attributed to a mutation in the H3N2 strain of the virus, a new study reports. Due to the mutation, most people receiving the egg-grown vaccine did not have immunity ...

Flu vaccine failed to protect young leukemia patients during cancer treatment

October 16, 2017
Young leukemia patients who were vaccinated against influenza were just as likely as their unvaccinated peers to develop flu, suggesting that additional steps are necessary to protect high-risk individuals. These findings ...

More health care workers need flu shots: CDC

September 30, 2016
(HealthDay)—More U.S. health care workers need to get their annual flu shots, a new government report shows.

Recommended for you

Scientists gain new insight on how antibodies interact with widespread respiratory virus

February 22, 2018
Scientists have found and characterized the activity of four antibodies produced by the human immune system that target an important protein found in respiratory syncytial virus (RSV), according to new research published ...

Study reveals how kidney disease happens

February 22, 2018
Monash researchers have solved a mystery, revealing how certain immune cells work together to instigate autoimmune kidney disease.

Past encounters with the flu shape vaccine response

February 20, 2018
New research on why the influenza vaccine was only modestly effective in recent years shows that immune history with the flu influences a person's response to the vaccine.

Building better tiny kidneys to test drugs and help people avoid dialysis

February 16, 2018
A free online kidney atlas built by USC researchers empowers stem cell scientists everywhere to generate more human-like tiny kidneys for testing new drugs and creating renal replacement therapies.

Study suggests expanded range for emerging tick-borne disease

February 16, 2018
Human cases of Borrelia miyamotoi, a tick-borne infection with some similarities to Lyme disease, were discovered in the eastern United States less than a decade ago. Now new research led by the Yale School of Public Health ...

Expanding Hepatitis C testing to all adults is cost-effective and improves outcomes

February 16, 2018
According to a new study, screening all adults for hepatitis C (HCV) is a cost-effective way to improve clinical outcomes of HCV and identify more infected people compared to current recommendations. Using a simulation model, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.